Material and Methods:
Workflow management software (Aria v 11.0™) has been in use in our department since October 2014. Prior to that, on-paper documentation was the predominant mode of communication between physicians and physicists for all forms of conformal treatment planning. Case records of patients who were treated with conformal radiation in the two month period prior to and after the implementation of workflow management were retrospectively evaluated. Proportion of cases for which treatment was started on the day of appointment was taken as a surrogate for work efficiency, which was the primary end point in this study. Other variables, like time available for target delineation (Td), treatment planning (Tp) and plan evaluation (Te) were analysed for different conformal techniques as secondary end points.
Results:
Of the 343 cases analysed, 190 were treated before implementation of workflow management (group 1), while 153 were treated after that (group 2). The mean gap between planning CT scans and date of treatment (overall planning time, To = Td + Tp + Te) was 5.25 days for group 1 and 6.53 days for group 2 (p=0.104). Among 3D-CRT plans, 29% were not started on the day of appointment in group 1, while 20% were not started on time in group 2 (p= 0.13). However, mean time available for planning and evaluation (Tp + Te) increased from 1.3 days in group 1 to 2.8 days in group 2 (p<0.01), without significant increase in overall planning time (To). In group 1, 71% of IMRT plans were not started on time, while only 27.2% were not started on time in group 2 (p<0.0001). Overall planning time (To) for IMRT decreased from a mean of 9.4 days to 5.9 days, after workflow management (p = 0.013), without significant compromise in the time available for planning and evaluation (Tp + Te). On multivariate analysis, workflow management was an independent factor determining work efficiency (p= 0.04) irrespective of the diagnosis, physician or physicist.
Conclusion: Implementation of workflow management resulted in significant improvement in work efficiency, as evidenced by an increase in proportion of cases started on time; this improvement was more substantial for IMRT planning. Time available for planning and evaluation also significantly increased with workflow management. Such improvements in work efficiency are essential for resource management in developing countries. Purpose or Objective: Substantial variations exist in the use of mastectomy and breast-conserving surgery (BCS or lumpectomy) to treat invasive cancer. No recent analysis has queried the broader role of individual surgeons play in the decision making process for BCS or mastectomy. The goal of this study was to evaluate the impact of individual surgeons on surgical procedures for definitive treatment of breast cancer in a large cohort of Medicare beneficiaries.
EP-1452 The impact of individual surgeons on the likelihood of mastectomy in breast cancer
Material and Methods: 36,068 women with non-metastatic breast cancer undergoing primary surgery (either BCS or mastectomy) were identified from Surveillance, Epidemiology, and End Results-Medicare linked database from 2000 to 2009. Medicare claims were used to determine surgery type and provider. Health service area stratified, multi-level, multivariable logistic models clustered by surgeon were used to determine the impact of surgeons on the likelihood of mastectomy while controlling for a patient's clinical and demographic covariates.
Results: 8,327 women were treated with mastectomy. 20.9% of the variation in the likelihood of mastectomy was due to the individual surgeon; 18.8% of this variation in surgery was due to a patient's clinical and demographic status. The median odds ratio, which allows for a direct comparison between the effect of the cluster variable (surgeon) and the odds ratio (OR) of fixed covariates, was 2.43. The only variables with a greater impact than surgeon were regional lymph node surgery (OR 3.0, 95% confidence interval [CI]: 2.79, 3.23) and primary tumor size 2-5 centimeters (OR 2.79, 95% CI: 2.62, 2.97).
Conclusion:
Surgeons have a substantial impact on a woman's likelihood of mastectomy for the treatment of invasive breast cancer. Further research should clarify the role of the patient in the decision making process. 
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